JPS62112562A - リウマチ因子の吸着材および吸着装置 - Google Patents
リウマチ因子の吸着材および吸着装置Info
- Publication number
- JPS62112562A JPS62112562A JP60250845A JP25084585A JPS62112562A JP S62112562 A JPS62112562 A JP S62112562A JP 60250845 A JP60250845 A JP 60250845A JP 25084585 A JP25084585 A JP 25084585A JP S62112562 A JPS62112562 A JP S62112562A
- Authority
- JP
- Japan
- Prior art keywords
- rheumatoid factor
- adsorbent
- vinyl compound
- vinyl
- crosslinking agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title description 2
- 239000003463 adsorbent Substances 0.000 claims description 39
- 229920002554 vinyl polymer Polymers 0.000 claims description 32
- 238000001179 sorption measurement Methods 0.000 claims description 26
- -1 vinyl compound Chemical class 0.000 claims description 24
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 239000003431 cross linking reagent Substances 0.000 claims description 16
- 229920001577 copolymer Polymers 0.000 claims description 9
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 claims description 6
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical group C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 claims description 5
- POSICDHOUBKJKP-UHFFFAOYSA-N prop-2-enoxybenzene Chemical compound C=CCOC1=CC=CC=C1 POSICDHOUBKJKP-UHFFFAOYSA-N 0.000 claims description 4
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000003446 ligand Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 241000282806 Rhinoceros Species 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 238000010557 suspension polymerization reaction Methods 0.000 description 2
- 108010094139 tumor-globulin Proteins 0.000 description 2
- IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 description 1
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- KXYAVSFOJVUIHT-UHFFFAOYSA-N 2-vinylnaphthalene Chemical compound C1=CC=CC2=CC(C=C)=CC=C21 KXYAVSFOJVUIHT-UHFFFAOYSA-N 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60250845A JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60250845A JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62112562A true JPS62112562A (ja) | 1987-05-23 |
JPH025098B2 JPH025098B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-01-31 |
Family
ID=17213864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60250845A Granted JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62112562A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008069346A (ja) * | 2006-08-18 | 2008-03-27 | Kaneka Corp | 架橋ポリマー粒子およびその製法 |
CN103611504A (zh) * | 2013-11-26 | 2014-03-05 | 重庆大学 | 一种用于血液灌流去除类风湿因子的吸附材料及其制备方法 |
-
1985
- 1985-11-11 JP JP60250845A patent/JPS62112562A/ja active Granted
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008069346A (ja) * | 2006-08-18 | 2008-03-27 | Kaneka Corp | 架橋ポリマー粒子およびその製法 |
CN103611504A (zh) * | 2013-11-26 | 2014-03-05 | 重庆大学 | 一种用于血液灌流去除类风湿因子的吸附材料及其制备方法 |
CN103611504B (zh) * | 2013-11-26 | 2015-10-28 | 重庆大学 | 一种用于血液灌流去除类风湿因子的吸附材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JPH025098B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6416487B1 (en) | Method of removing beta-2 microglobulin from blood | |
US11020521B2 (en) | Hemocompatibility modifiers for cross-linked polymeric material | |
EP0143369A2 (en) | A porous adsorbent for adsorbing low density lipoproteins | |
BR112013005793B1 (pt) | sistema de polímero seletivo por tamanho | |
CN108136112A (zh) | 用于从生物流体中去除基于蛋白质的毒素和钾的多功能血液相容性多孔聚合物珠吸着剂 | |
GB2140424A (en) | An adsorbent for absorbing thereonto an autoantibody and/or immune complexes from a body fluid | |
JPS6145773A (ja) | 体液浄化材 | |
CN1177620C (zh) | 除白细胞的过滤介质 | |
JP4997770B2 (ja) | 吸着器 | |
JPS62112562A (ja) | リウマチ因子の吸着材および吸着装置 | |
JPS59186558A (ja) | リウマチ因子および/またはその免疫複合体の吸着材 | |
JPH0229260A (ja) | 全血処理用吸着器 | |
JPH0611333B2 (ja) | 免疫複合体の吸着体およびそれを用いた免疫複合体の除去装置 | |
JPS5810055A (ja) | 免疫吸着器の製造方法 | |
JPS59186559A (ja) | 自己抗体および/または免疫複合体吸着材 | |
JPS61253071A (ja) | 血液浄化用装置 | |
JPH0622632B2 (ja) | 吸着体および除去装置 | |
JPH0316639A (ja) | 吸着体およびそれを用いた除去装置 | |
JPS6361024B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
JPS5861752A (ja) | 悪性物質の吸着材 | |
JPS59186560A (ja) | 自己抗体、免疫複合体の吸着材 | |
WO2023008561A1 (ja) | 血液成分吸着材料 | |
JPS62244442A (ja) | 低比重リポ蛋白質吸着材およびその製造方法 | |
JPS5854961A (ja) | 血液浄化治療用装置 | |
JPS62179469A (ja) | 体液浄化用吸着材および吸着装置 |